Susan M. Stalnecker

CIK: 0001221375

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)7 (70.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BVS

Bioventus Inc.

Director

LDOS

Leidos Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

BVS
Bioventus Inc.
Jun 3, 2026
Award(A)
Restricted Stock Units
Direct
25.1K shares-
BVS
Bioventus Inc.
Jun 2, 2026
Exercise(M)
Direct
32.3K shares-
BVS
Bioventus Inc.
Jun 3, 2025
Award(A)
Restricted Stock Units
Direct
32.3K shares-
BVS
Bioventus Inc.
Jun 2, 2025
Exercise(M)
Direct
26.5K shares-
LDOS
Leidos Holdings, Inc.
Feb 18, 2025
Exercise(M)
Direct
1.8K shares at avg. $104.06$184K
LDOS
Leidos Holdings, Inc.
Feb 18, 2025
Exercise(M)
Direct
2.3K shares at avg. $79.45$182K
LDOS
Leidos Holdings, Inc.
Feb 18, 2025
Tax Payment(F)
Direct
8.3K shares at avg. $132.26$1.1M
LDOS
Leidos Holdings, Inc.
Feb 18, 2025
Exercise(M)
Direct
2.1K shares at avg. $103.90$221K
LDOS
Leidos Holdings, Inc.
Feb 18, 2025
Exercise(M)
Direct
3.3K shares at avg. $75.02$251K
LDOS
Leidos Holdings, Inc.
Feb 18, 2025
Exercise(M)
Direct
4.1K shares at avg. $63.08$257K

		Type	Shares	Price		Ownership
Jun 3, 2026	BVS Bioventus Inc.	Award(A) Restricted Stock Units	25,146	-	-	Direct
Jun 2, 2026	BVS Bioventus Inc.	Exercise(M)	32,282	-	$0	Direct
Jun 3, 2025	BVS Bioventus Inc.	Award(A) Restricted Stock Units	32,282	-	-	Direct
Jun 2, 2025	BVS Bioventus Inc.	Exercise(M)	26,493	-	-	Direct
Feb 18, 2025	LDOS Leidos Holdings, Inc.	Exercise(M)	1,769	$104.06	$184,082	Direct
Feb 18, 2025	LDOS Leidos Holdings, Inc.	Exercise(M)	2,296	$79.45	$182,417	Direct
Feb 18, 2025	LDOS Leidos Holdings, Inc.	Tax Payment(F)	8,278	$132.26	$1,094,848	Direct
Feb 18, 2025	LDOS Leidos Holdings, Inc.	Exercise(M)	2,123	$103.90	$220,580	Direct
Feb 18, 2025	LDOS Leidos Holdings, Inc.	Exercise(M)	3,345	$75.02	$250,942	Direct
Feb 18, 2025	LDOS Leidos Holdings, Inc.	Exercise(M)	4,070	$63.08	$256,736	Direct

1-10 of 10 transactions

About STALNECKER SUSAN M

STALNECKER SUSAN M (SEC CIK 0001221375) files insider reports with the SEC as Director of Bioventus Inc. (BVS) and Director of Leidos Holdings, Inc. (LDOS).

Signal8 holds 3 ownership filings by STALNECKER SUSAN M, all Form 4s, filed between Feb 19, 2025 and Jun 4, 2026. Those filings report 10 transactions, from Feb 18, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on STALNECKER SUSAN M's filings is in DURHAM, NC.

Recent filings by STALNECKER SUSAN M

Jun 3, 2026: Grant or award of BVS derivative securities (Form 4, code A).
Jun 2, 2026: Option exercise of BVS shares (Form 4, code M).
Jun 3, 2025: Grant or award of BVS derivative securities (Form 4, code A).
Jun 2, 2025: Option exercise of BVS shares (Form 4, code M).
Feb 18, 2025: Option exercises of LDOS shares (2 lines, Form 4, code M).

Other insiders filing for Bioventus Inc. (BVS)

Bartholdson John A., Director
SUTTER MARTIN P, Director
NOHRA GUY P, Director
NEELS GUIDO J, Director
McMurry-Heath Michelle, Director
Ladone Mary Kay, Director

How to read Form 4 transaction codes